Exact Mass: 182.0375

Exact Mass Matches: 182.0375

Found 176 metabolites which its exact mass value is equals to given mass value 182.0375, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

1-Methyluric acid

1-methyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C6H6N4O3 (182.044)


1-Methyluric acid is one of the three main theophylline metabolites in man. 1-Methyluric acid is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152, 4039734, 9890610) [HMDB] 1-Methyluric acid is one of the three main theophylline metabolites in man. 1-Methyluric acid is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline, and theobromine). Methyluric acids can be distinguished from uric acid via simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase, or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 superfamily, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis (PMID:11712316, 15833286, 3506820, 15013152, 4039734, 9890610).

   

2,4-Dinitrotoluene

2,4-Dinitro-1-methylbenzene

C7H6N2O4 (182.0328)


CONFIDENCE standard compound; INTERNAL_ID 40

   

Acenaphthoquinone

1,2-Diketoacenaphthene

C12H6O2 (182.0368)


   

2,6-Dinitrotoluene

1-Methyl-2,6-dinitrobenzene

C7H6N2O4 (182.0328)


   

Z-Furan

3-(5-Nitro-2-furyl)acrylamide

C7H6N2O4 (182.0328)


   

7-Methyluric acid

7,9-dihydro-7-methyl-1H-purine-2,6,8(3H)-trione

C6H6N4O3 (182.044)


7-Methyluric acid is the minor urinary metabolites of caffeine. Caffeine is metabolized mainly in the liver undergoing demethylation and oxidation. [HMDB] 7-Methyluric acid is the minor urinary metabolites of caffeine. Caffeine is metabolized mainly in the liver undergoing demethylation and oxidation.

   

3,5-DINITROTOLUENE

3,5-DINITROTOLUENE

C7H6N2O4 (182.0328)


   

5-Nitroanthranilate

2-AMINO-5-NITROBENZOIC ACID

C7H6N2O4 (182.0328)


   

2,4-DINITROTOLUENE

2,4-DINITROTOLUENE

C7H6N2O4 (182.0328)


D009676 - Noxae > D002273 - Carcinogens

   

9-Methyluric acid

9-methyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C6H6N4O3 (182.044)


9-Methyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 9-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152) [HMDB] 9-Methyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 9-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID:11712316, 15833286, 3506820, 15013152).

   

3-Methyluric acid

3-methyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C6H6N4O3 (182.044)


3-Methyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 3-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152) [HMDB] 3-Methyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 3-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152).

   

2,3-Dinitrotoluene

1-methyl-2,3-dinitrobenzene

C7H6N2O4 (182.0328)


   

5-Amino-2-nitrobenzoic acid

2-nitro-5-aminobenzoic acid

C7H6N2O4 (182.0328)


   

6-[Ethoxy(mercapto)methylidene]-1-cyclohexa-2,4-dienone

6-[Ethoxy(mercapto)methylidene]-1-cyclohexa-2,4-dienone

C9H10O2S (182.0401)


   

7-Methyluric acid

7,9-dihydro-7-methyl-1H-purine-2,6,8(3H)-trione

C6H6N4O3 (182.044)


   

dinitrotoluene

2,3-DINITROTOLUENE

C7H6N2O4 (182.0328)


   

2-(3,3-dimethoxy-1-propynyl)-thiophene

2-(3,3-dimethoxy-1-propynyl)-thiophene

C9H10O2S (182.0401)


   

3,3-Disulfanediylbis(propan-1-ol)

3,3-Disulfanediylbis(propan-1-ol)

C6H14O2S2 (182.0435)


   

4-AMINOPYRIDINE-2,3-DICARBOXYLIC ACID

4-AMINOPYRIDINE-2,3-DICARBOXYLIC ACID

C7H6N2O4 (182.0328)


   

3-(4-Fluorophenyl)-2-oxopropanoic acid

3-(4-Fluorophenyl)-2-oxopropanoic acid

C9H7FO3 (182.0379)


   

Antibiotic G-7063-2

Antibiotic G-7063-2

C7H6N2O4 (182.0328)


   

9-Methyluric acid

7,9-dihydro-9-Methyl-1H-purine-2,6,8(3H)-trione

C6H6N4O3 (182.044)


   

1-Methyluric acid

1-Methyluric acid

C6H6N4O3 (182.044)


An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trione substituted by a methyl group at N-1. It is one of the metabolites of caffeine found in human urine.

   

4-Nitroanthranilic acid

2-Amino-4-nitrobenzoic acid

C7H6N2O4 (182.0328)


CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3787; ORIGINAL_PRECURSOR_SCAN_NO 3785 CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3808; ORIGINAL_PRECURSOR_SCAN_NO 3805 CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3790; ORIGINAL_PRECURSOR_SCAN_NO 3785 CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3777; ORIGINAL_PRECURSOR_SCAN_NO 3775 CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3856; ORIGINAL_PRECURSOR_SCAN_NO 3855 CONFIDENCE standard compound; INTERNAL_ID 394; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3797; ORIGINAL_PRECURSOR_SCAN_NO 3793

   

3-Methyluric acid; LC-tDDA; CE10

3-Methyluric acid; LC-tDDA; CE10

C6H6N4O3 (182.044)


   

3-Methyluric acid; LC-tDDA; CE20

3-Methyluric acid; LC-tDDA; CE20

C6H6N4O3 (182.044)


   

3-Methyluric acid; LC-tDDA; CE30

3-Methyluric acid; LC-tDDA; CE30

C6H6N4O3 (182.044)


   

3-Methyluric acid; LC-tDDA; CE40

3-Methyluric acid; LC-tDDA; CE40

C6H6N4O3 (182.044)


   

1-Methyluric acid; LC-tDDA; CE10

1-Methyluric acid; LC-tDDA; CE10

C6H6N4O3 (182.044)


   

1-Methyluric acid; LC-tDDA; CE20

1-Methyluric acid; LC-tDDA; CE20

C6H6N4O3 (182.044)


   

1-Methyluric acid; LC-tDDA; CE30

1-Methyluric acid; LC-tDDA; CE30

C6H6N4O3 (182.044)


   

1-Methyluric acid; LC-tDDA; CE40

1-Methyluric acid; LC-tDDA; CE40

C6H6N4O3 (182.044)


   

7-Methyluric acid; LC-tDDA; CE10

7-Methyluric acid; LC-tDDA; CE10

C6H6N4O3 (182.044)


   

7-Methyluric acid; LC-tDDA; CE20

7-Methyluric acid; LC-tDDA; CE20

C6H6N4O3 (182.044)


   

7-Methyluric acid; LC-tDDA; CE30

7-Methyluric acid; LC-tDDA; CE30

C6H6N4O3 (182.044)


   

7-Methyluric acid; LC-tDDA; CE40

7-Methyluric acid; LC-tDDA; CE40

C6H6N4O3 (182.044)


   

3-Methyluric acid; AIF; CE30; CorrDec

3-Methyluric acid; AIF; CE30; CorrDec

C6H6N4O3 (182.044)


   

3-Methyluric acid; AIF; CE0; MS2Dec

3-Methyluric acid; AIF; CE0; MS2Dec

C6H6N4O3 (182.044)


   

3-Methyluric acid; AIF; CE10; MS2Dec

3-Methyluric acid; AIF; CE10; MS2Dec

C6H6N4O3 (182.044)


   

3-Methyluric acid; AIF; CE30; MS2Dec

3-Methyluric acid; AIF; CE30; MS2Dec

C6H6N4O3 (182.044)


   

1-Methyluric acid; AIF; CE0; CorrDec

1-Methyluric acid; AIF; CE0; CorrDec

C6H6N4O3 (182.044)


   

1-Methyluric acid; AIF; CE10; CorrDec

1-Methyluric acid; AIF; CE10; CorrDec

C6H6N4O3 (182.044)


   

1-Methyluric acid; AIF; CE30; CorrDec

1-Methyluric acid; AIF; CE30; CorrDec

C6H6N4O3 (182.044)


   

1-Methyluric acid; AIF; CE10; MS2Dec

1-Methyluric acid; AIF; CE10; MS2Dec

C6H6N4O3 (182.044)


   

1-Methyluric acid; AIF; CE30; MS2Dec

1-Methyluric acid; AIF; CE30; MS2Dec

C6H6N4O3 (182.044)


   

7-Methyluric acid; AIF; CE0; MS2Dec

7-Methyluric acid; AIF; CE0; MS2Dec

C6H6N4O3 (182.044)


   

7-Methyluric acid; AIF; CE10; MS2Dec

7-Methyluric acid; AIF; CE10; MS2Dec

C6H6N4O3 (182.044)


   

7-Methyluric acid; AIF; CE30; MS2Dec

7-Methyluric acid; AIF; CE30; MS2Dec

C6H6N4O3 (182.044)


   

3-METHYLURIC ACID

4,9-dihydro-3-Methyl-1H-purine-2,6,8(3H)-trione

C6H6N4O3 (182.044)


   

2-METHYL-5-(METHYLTHIO)BENZOIC ACID

2-METHYL-5-(METHYLTHIO)BENZOIC ACID

C9H10O2S (182.0401)


   

8-Chloro-6-Methyl-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine

8-Chloro-6-Methyl-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine

C7H7ClN4 (182.0359)


   

methyl 3-methylsulfanylbenzoate

methyl 3-methylsulfanylbenzoate

C9H10O2S (182.0401)


   

O-(4-Nitrobenzoyl)hydroxylamine

O-(4-Nitrobenzoyl)hydroxylamine

C7H6N2O4 (182.0328)


   

3,4-dinitrotoluene

3,4-dinitrotoluene

C7H6N2O4 (182.0328)


   

3-Amino-4-nitrobenzoic acid

3-Amino-4-nitrobenzoic acid

C7H6N2O4 (182.0328)


   

methyl 6-nitropyridine-2-carboxylate

methyl 6-nitropyridine-2-carboxylate

C7H6N2O4 (182.0328)


   

5,7-Difluoroquinazolin-4(3H)-one

5,7-Difluoroquinazolin-4(3H)-one

C8H4F2N2O (182.0292)


   

3-Amino-5-nitrobenzoic acid

3-Amino-5-nitrobenzoic acid

C7H6N2O4 (182.0328)


   

Methyl (3-sulfanylphenyl)acetate

Methyl (3-sulfanylphenyl)acetate

C9H10O2S (182.0401)


   

Cyclohexanecarbonyl chloride, 4,4-difluoro- (9CI)

Cyclohexanecarbonyl chloride, 4,4-difluoro- (9CI)

C7H9ClF2O (182.031)


   

4,5,6,7-Tetrahydro-2-benzothiophene-1-carboxylic acid

Benzo[c]thiophene-1-carboxylicacid, 4,5,6,7-tetrahydro-

C9H10O2S (182.0401)


   

4-Amino-3-nitrobenzoic acid

4-Amino-3-nitrobenzoic acid

C7H6N2O4 (182.0328)


   

3,5-DIFLUOROANISOLE

3,5-DIFLUOROANISOLE

C7H4F2N4 (182.0404)


   

3-Amino-2-nitrobenzoic acid

3-Amino-2-nitrobenzoic acid

C7H6N2O4 (182.0328)


   

2-Amino-3-nitrobenzoic acid

2-Amino-3-nitrobenzoic acid

C7H6N2O4 (182.0328)


   

6-Nitro-1,3-benzodioxol-5-amine

6-Nitro-1,3-benzodioxol-5-amine

C7H6N2O4 (182.0328)


   

4,5,6,7-TETRAHYDROBENZO[B]THIOPHENE-3-CARBOXYLIC ACID

4,5,6,7-TETRAHYDROBENZO[B]THIOPHENE-3-CARBOXYLIC ACID

C9H10O2S (182.0401)


   

2,7-Diazaspiro[4.4]nonane-1,3,6,8-tetraone

2,7-Diazaspiro[4.4]nonane-1,3,6,8-tetraone

C7H6N2O4 (182.0328)


   

4-(Methylthio)phenylacetic acid

4-(Methylthio)phenylacetic acid

C9H10O2S (182.0401)


   

1H-Pyrazolo[3,4-d]pyrimidine, 4-chloro-1,6-dimethyl

1H-Pyrazolo[3,4-d]pyrimidine, 4-chloro-1,6-dimethyl

C7H7ClN4 (182.0359)


   

Ethyl 2-sulfanylbenzoate

Ethyl 2-sulfanylbenzoate

C9H10O2S (182.0401)


   

6-Chloro-1-methyl-1H-pyrazolo[3,4-b]pyridin-3-amine

6-Chloro-1-methyl-1H-pyrazolo[3,4-b]pyridin-3-amine

C7H7ClN4 (182.0359)


   

TRANS-2-(4-CHLOROPHENYL)VINYLBORONIC ACID

TRANS-2-(4-CHLOROPHENYL)VINYLBORONIC ACID

C8H8BClO2 (182.0306)


   

4-methyl-2-methylsulfanylbenzoic acid

4-methyl-2-methylsulfanylbenzoic acid

C9H10O2S (182.0401)


   

2-Methoxy-3-nitroisonicotinaldehyde

2-Methoxy-3-nitroisonicotinaldehyde

C7H6N2O4 (182.0328)


   

METHYL 3-(3-METHYL-2-THIENYL)ACRYLATE

METHYL 3-(3-METHYL-2-THIENYL)ACRYLATE

C9H10O2S (182.0401)


   
   

4-amino-5-nitropyridine-3-carboxamide

4-amino-5-nitropyridine-3-carboxamide

C6H6N4O3 (182.044)


   

METHYL 4-(METHYLTHIO)BENZOATE

METHYL 4-(METHYLTHIO)BENZOATE

C9H10O2S (182.0401)


   

benzyl 2-sulfanylacetate

benzyl 2-sulfanylacetate

C9H10O2S (182.0401)


   

4-Methyl-5-Nitro-2-Pyridinecarboxylic Acid

4-Methyl-5-Nitro-2-Pyridinecarboxylic Acid

C7H6N2O4 (182.0328)


   

Methyl(phenylthio)acetate

Methyl (phenylthio)acetate

C9H10O2S (182.0401)


   

2-ethylsulfanylbenzoic acid

2-ethylsulfanylbenzoic acid

C9H10O2S (182.0401)


   

methyl 3-nitropyridine-2-carboxylate

methyl 3-nitropyridine-2-carboxylate

C7H6N2O4 (182.0328)


   

7-Chloro-5-methyl-1H-pyrazolo[4,3-b]pyridin-3-amine

7-Chloro-5-methyl-1H-pyrazolo[4,3-b]pyridin-3-amine

C7H7ClN4 (182.0359)


   

Formamide, N-(4-hydroxy-2-nitrophenyl)-

Formamide, N-(4-hydroxy-2-nitrophenyl)-

C7H6N2O4 (182.0328)


   

2-(2-hydroxyethoxy)ethyl chloroacetate

2-(2-hydroxyethoxy)ethyl chloroacetate

C6H11ClO4 (182.0346)


   

Methyl 2-(methylthio)benzoate

Methyl 2-(methylsulfanyl)benzoate

C9H10O2S (182.0401)


   

(Benzylthio)acetic acid

(Benzylthio)acetic acid

C9H10O2S (182.0401)


   

4,5,6,7-Tetrahydrobenzo[b]thiophene-2-carboxylic acid

4,5,6,7-Tetrahydrobenzo[b]thiophene-2-carboxylic acid

C9H10O2S (182.0401)


   

6-Methyl-4-nitropyridine-2-carboxylic acid

6-Methyl-4-nitropyridine-2-carboxylic acid

C7H6N2O4 (182.0328)


   

3-Methyl-4-nitropyridine-2-carboxylic acid

3-Methyl-4-nitropyridine-2-carboxylic acid

C7H6N2O4 (182.0328)


   

2-propenoic acid, 3-(3-thienyl)-, ethyl ester

2-propenoic acid, 3-(3-thienyl)-, ethyl ester

C9H10O2S (182.0401)


   

2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

C7H7ClN4 (182.0359)


   

2-(5-Nitropyridin-2-yl)acetic acid

2-(5-Nitropyridin-2-yl)acetic acid

C7H6N2O4 (182.0328)


   

2-(3-Nitropyridin-2-yl)acetic acid

2-(3-Nitropyridin-2-yl)acetic acid

C7H6N2O4 (182.0328)


   

7-chloro-1-ethylpyrazolo[4,3-d]pyrimidine

7-chloro-1-ethylpyrazolo[4,3-d]pyrimidine

C7H7ClN4 (182.0359)


   

5-Phosphonopentanoic acid

5-Phosphonopentanoic acid

C5H11O5P (182.0344)


   

N-(Carbamoylmethyl)taurine

N-(Carbamoylmethyl)taurine

C4H10N2O4S (182.0361)


   

Succinimidyl Cyanoacetate

Succinimidyl Cyanoacetate

C7H6N2O4 (182.0328)


   

3-METHOXY-4-METHYLSULFANYL-BENZALDEHYDE

3-METHOXY-4-METHYLSULFANYL-BENZALDEHYDE

C9H10O2S (182.0401)


   

Phenylmethylvinylchlorosilane

Vinyl Phenyl Methyl Chlorosilane

C9H11ClSi (182.0319)


   
   

2-Hydroxy-3-nitrobenzamide

2-Hydroxy-3-nitrobenzamide

C7H6N2O4 (182.0328)


   

2-Hydroxy-4-nitrobenzamide

2-Hydroxy-4-nitrobenzamide

C7H6N2O4 (182.0328)


   

2-Hydroxy-5-nitrobenzamide

2-Hydroxy-5-nitrobenzamide

C7H6N2O4 (182.0328)


   

7-Chloro-2,5-dimethyl-[1,2,4]triazolo[1,5-c]pyrimidine

7-Chloro-2,5-dimethyl-[1,2,4]triazolo[1,5-c]pyrimidine

C7H7ClN4 (182.0359)


   

4-Amino-2,6-pyridinedicarboxylic acid

4-Amino-2,6-pyridinedicarboxylic acid

C7H6N2O4 (182.0328)


   

Methyl 3-fluoro-4-formylbenzoate

Methyl 3-fluoro-4-formylbenzoate

C9H7FO3 (182.0379)


   

3,7-Diazabicyclo[3.3.1]nonane-2,4,6,8-tetrone

3,7-Diazabicyclo[3.3.1]nonane-2,4,6,8-tetrone

C7H6N2O4 (182.0328)


   

7-chloro-2-ethylpyrazolo[4,3-d]pyrimidine

7-chloro-2-ethylpyrazolo[4,3-d]pyrimidine

C7H7ClN4 (182.0359)


   

3-(Phenylsulfanyl)propanoic acid

3-(Phenylsulfanyl)propanoic acid

C9H10O2S (182.0401)


   

2-Methyl-3-nitropyridine-6-carboxylic acid

2-Methyl-3-nitropyridine-6-carboxylic acid

C7H6N2O4 (182.0328)


   

5-(TRIFLUOROMETHYL)DIHYDROPYRIMIDINE-2,4(1H,3H)-DIONE

5-(TRIFLUOROMETHYL)DIHYDROPYRIMIDINE-2,4(1H,3H)-DIONE

C5H5F3N2O2 (182.0303)


   

p-tolyl vinyl sulphone

p-tolyl vinyl sulphone

C9H10O2S (182.0401)


   

4-(ethylthio)benzoic acid

4-(ethylthio)benzoic acid

C9H10O2S (182.0401)


   

1H-Benzimidazole-2-methanethiol,5-fluoro-(9CI)

1H-Benzimidazole-2-methanethiol,5-fluoro-(9CI)

C8H7FN2S (182.0314)


   

2-MERCAPTO-1-(4-METHOXYPHENYL)ETHANONE

2-MERCAPTO-1-(4-METHOXYPHENYL)ETHANONE

C9H10O2S (182.0401)


   

6,7-Difluoroquinazolin-4-ol

6,7-Difluoroquinazolin-4-ol

C8H4F2N2O (182.0292)


   

6-METHYL-3-NITRO-PYRIDINE-2-CARBOXYLIC ACID

6-METHYL-3-NITRO-PYRIDINE-2-CARBOXYLIC ACID

C7H6N2O4 (182.0328)


   

Trimethyl phosphonoacetate

Methyl 2-(dimethoxyphosphoryl)acetate

C5H11O5P (182.0344)


   

Methyl 2-fluoro-4-formylbenzoate

Methyl 2-fluoro-4-formylbenzoate

C9H7FO3 (182.0379)


   

5-Methyl-2,3-pyrazinedicarboxylic acid

5-Methyl-2,3-pyrazinedicarboxylic acid

C7H6N2O4 (182.0328)


   

2-(3-methylsulfanylphenyl)acetic acid

2-(3-methylsulfanylphenyl)acetic acid

C9H10O2S (182.0401)


   

3,6-DIOXA-1,8-OCTANEDITHIOL

3,6-DIOXA-1,8-OCTANEDITHIOL

C6H14O2S2 (182.0435)


   

1H-Benzimidazole-5,6-diamine,2-chloro-(9CI)

1H-Benzimidazole-5,6-diamine,2-chloro-(9CI)

C7H7ClN4 (182.0359)


   

2-Amino-6-nitrobenzoic acid

2-Amino-6-nitrobenzoic acid

C7H6N2O4 (182.0328)


   

Methyl 4-fluoro-3-formylbenzoate

Methyl 4-fluoro-3-formylbenzoate

C9H7FO3 (182.0379)


   

6-Fluoro-1,3-benzodioxene-8-carbaldehyde

6-Fluoro-1,3-benzodioxene-8-carbaldehyde

C9H7FO3 (182.0379)


   

Methyl glycylglycinate hydrochloride

Methyl glycylglycinate hydrochloride

C5H11ClN2O3 (182.0458)


   

(E)-ETHYL 3-(THIOPHEN-2-YL)ACRYLATE

(E)-ETHYL 3-(THIOPHEN-2-YL)ACRYLATE

C9H10O2S (182.0401)


   

Allyl phenyl sulfone

Allyl phenyl sulfone

C9H10O2S (182.0401)


   

2-amino-3,5-pyridinedicarboxylic acid

2-amino-3,5-pyridinedicarboxylic acid

C7H6N2O4 (182.0328)


   

7-Chloro-1,3-dimethyl-1H-pyrazolo[4,3-d]pyrimidine

7-Chloro-1,3-dimethyl-1H-pyrazolo[4,3-d]pyrimidine

C7H7ClN4 (182.0359)


   

2-Hydroxy-2-(methylthio)acetophenone

2-Hydroxy-2-(methylthio)acetophenone

C9H10O2S (182.0401)


   

CHEMPACIFIC 38132

CHEMPACIFIC 38132

C7H6N2O4 (182.0328)


   

6-carbamoyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid

6-carbamoyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid

C7H6N2O4 (182.0328)


   

Methyl 3-nitroisonicotinate

Methyl 3-nitroisonicotinate

C7H6N2O4 (182.0328)


   

4-mercaptohydrocinnamic acid

4-mercaptohydrocinnamic acid

C9H10O2S (182.0401)


   

Benzene,2-methyl-1,4-dinitro-

Benzene,2-methyl-1,4-dinitro-

C7H6N2O4 (182.0328)


   

4-((METHYLTHIO)METHYL)BENZOIC ACID

4-((METHYLTHIO)METHYL)BENZOIC ACID

C9H10O2S (182.0401)


   

6-methoxy-3-nitropyridine-2-carbaldehyde

6-methoxy-3-nitropyridine-2-carbaldehyde

C7H6N2O4 (182.0328)


   

Imidazo[1,2-b]pyridazine-3-methanamine, 6-chloro-

Imidazo[1,2-b]pyridazine-3-methanamine, 6-chloro-

C7H7ClN4 (182.0359)


   

1,2-Dithiocane-3,8-diol

1,2-Dithiocane-3,8-diol

C6H14O2S2 (182.0435)


   

2-Methyl-5-nitro-3-pyridinecarboxylic acid

2-Methyl-5-nitro-3-pyridinecarboxylic acid

C7H6N2O4 (182.0328)


   

METHYL 5-NITROPICOLINATE

METHYL 5-NITROPICOLINATE

C7H6N2O4 (182.0328)


   

4-Methyl phenyl thioacetic acid

4-Methyl phenyl thioacetic acid

C9H10O2S (182.0401)


   

Ethanone, 1-(1,3-benzodioxol-5-yl)-2-fluoro- (9CI)

Ethanone, 1-(1,3-benzodioxol-5-yl)-2-fluoro- (9CI)

C9H7FO3 (182.0379)


   

4-Amino-2-nitrobenzoic acid

4-Amino-2-nitrobenzoic acid

C7H6N2O4 (182.0328)


   

2,6-diamino-7,9-dihydropurine-8-thione

2,6-diamino-7,9-dihydropurine-8-thione

C5H6N6S (182.0375)


   

6-OXO-1,6-DIHYDRO-PYRAZINE-2,3-DICARBOXYLIC ACID DIAMIDE

6-OXO-1,6-DIHYDRO-PYRAZINE-2,3-DICARBOXYLIC ACID DIAMIDE

C6H6N4O3 (182.044)


   

3-Hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylate

3-Hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylate

C8H8NO4- (182.0453)


   

5-Pyridoxate

5-Pyridoxate

C8H8NO4- (182.0453)


   

2-[(2-Amino-2-oxoethyl)ammonio]ethanesulfonate

2-[(2-Amino-2-oxoethyl)ammonio]ethanesulfonate

C4H10N2O4S (182.0361)


   

3-Amino-2-hydroxy-4-methoxybenzoate

3-Amino-2-hydroxy-4-methoxybenzoate

C8H8NO4- (182.0453)


   

4-Methoxy-1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate

4-Methoxy-1-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate

C8H8NO4- (182.0453)


   

alpha-Fluoro-4-hydroxy-cis-cinnamic acid

alpha-Fluoro-4-hydroxy-cis-cinnamic acid

C9H7FO3 (182.0379)


   
   

Phosphono valerate

Phosphono valerate

C5H11O5P (182.0344)


   

(Z)-N-hydroxy-2-(4-hydroxyphenyl)acetimidothioate

(Z)-N-hydroxy-2-(4-hydroxyphenyl)acetimidothioate

C8H8NO2S- (182.0276)


   

Phosphono 3-methylbutanoate

Phosphono 3-methylbutanoate

C5H11O5P (182.0344)


   

Phosphoric acid (E)-3-methyl-4-hydroxy-2-butenyl ester

Phosphoric acid (E)-3-methyl-4-hydroxy-2-butenyl ester

C5H11O5P (182.0344)


   

Phosphono 2-methylbutanoate

Phosphono 2-methylbutanoate

C5H11O5P (182.0344)


   

Propyl propane thiosulfonate

Propyl propane thiosulfonate

C6H14O2S2 (182.0435)


   

3-(5-Nitro-2-furyl)acrylamide

3-(5-Nitro-2-furyl)acrylamide

C7H6N2O4 (182.0328)


   

(E)-Methyl 4-(thiophen-2-yl)but-3-enoate

(E)-Methyl 4-(thiophen-2-yl)but-3-enoate

C9H10O2S (182.0401)


   

(R)-2-hydroxy-4-(hydroxymethylphosphinyl)butyric acid

(R)-2-hydroxy-4-(hydroxymethylphosphinyl)butyric acid

C5H11O5P (182.0344)


   

2-AMINO-5-NITROBENZOIC ACID

2-AMINO-5-NITROBENZOIC ACID

C7H6N2O4 (182.0328)


   

2,6-DNT

2,6-DINITROTOLUENE

C7H6N2O4 (182.0328)


   

2-Amino-4-nitrobenzoic acid

2-Amino-4-nitrobenzoic acid

C7H6N2O4 (182.0328)


   

5-Nitroanthranilic acid

5-Nitroanthranilic acid

C7H6N2O4 (182.0328)


An aminobenzoic acid in which the the amino group is ortho- to the carboxylic acid group, and which is substituted para- to the amino group by a nitro group.

   

4-Pyridoxate

4-Pyridoxate

C8H8NO4 (182.0453)


A pyridoxate that is the conjugate base of 4-pyridoxic acid, obtained by deprotonation of the carboxy group.

   

5-Pyridoxate

5-Pyridoxate

C8H8NO4 (182.0453)


A pyridoxate that is the conjugate base of 5-pyridoxic acid, obtained by deprotonation of the carboxy group.

   

Methyluric acid

Methyluric acid

C6H6N4O3 (182.044)


   

4-amino-2,5-dioxo-7-oxabicyclo[4.1.0]hept-3-ene-3-carboximidic acid

4-amino-2,5-dioxo-7-oxabicyclo[4.1.0]hept-3-ene-3-carboximidic acid

C7H6N2O4 (182.0328)


   

4-hydroxy-3-nitrobenzenecarboximidic acid

4-hydroxy-3-nitrobenzenecarboximidic acid

C7H6N2O4 (182.0328)